Journal of The Academy of Clinical Microbiologists

Register      Login

VOLUME 19 , ISSUE 1 ( January-June, 2017 ) > List of Articles

Original Article

Role of IgG Chlamydia antibody in predicting tubal factor infertility

Dolly Johnrose, Geetha Raveendran, Sheila Balakrishnan, Anitha Malathy

Keywords : Chlamydia trachomatis, IgG antibody, tubal infertility

Citation Information : Johnrose D, Raveendran G, Balakrishnan S, Malathy A. Role of IgG Chlamydia antibody in predicting tubal factor infertility. 2017; 19 (1):32-35.

DOI: 10.4103/jacm.jacm_54_16

License: CC BY-NC 4.0

Published Online: 17-08-2024

Copyright Statement:  Copyright © 2017; Wolters Kluwer India Pvt. Ltd.


Abstract

BACKGROUND AND OBJECTIVES: Infertility is not a health problem, but a serious psychological trauma that affects the social status of women in the society. Treatment of infertility imposes a heavy economic burden on the family. Infertility can be due to a single or combination of causes and identification of the cause is essential for the proper management. Chlamydia trachomatis is one of the most common causes of tubal factor infertility. No recent study has been done in Kerala to assess the burden of C. trachomatis in genitourinary infections. The aim of the study was to assess the role of C. trachomatis IgG antibody in patients with tubal factor infertility among women with primary or secondary infertility attending the fertility clinic in a tertiary care hospital in Kerala. MATERIALS AND METHODS: The study was done for one year and the sample size included 95 cases and 63 age-matched controls. Tubal disease was diagnosed by laparoscopy or hysterosalpingography. Serum samples of all the patients and controls were tested for C. trachomatis IgG antibodies by enzyme-linked immunosorbent assay. RESULTS: Of the 95 patients with tubal pathology, 14 (14.7%) had antibodies to C. trachomatis. Of the 63 patients with normal tubes, 12 (19%) had antibodies. However, of the 26 patients who were positive for Chlamydia antibodies, 14 (53.8%) had tubal disease. CONCLUSIONS: The prevalence of Chlamydia IgG in our study among women attending fertility clinic for the treatment of primary or secondary infertility is 26/158 (16.5%). Fifty-one (81%) patients had normal tubes.


PDF Share
  1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted diseases: Overview and estimates. Geneva: World Health Organization; 2011.
  2. Bébéar C, de Barbeyrac B. Genital Chlamydia trachomatis infections. Clin Microbiol Infect 2009;15:4-10.
  3. Sharma M, Nayak N, Malhotra S, Kumar B, Hemal A. Chlamydiazyme test for rapid detection of Chlamydia trachomatis. Indian J Med Res 1989;89:87-91.
  4. Ray K, Yadav SC. Prevalance of C. trachomatis and other sexually transmitted pathogens in female reproductive tract infections. Indian J Med Microbiol 1997;15:1-4.
  5. Low N. Screen project team. Publication of report on Chlamydia control activities in Europe. Euro Surveill 2008;13. pii: 18924.
  6. van Bergen J, Götz HM, Richardus JH, Hoebe CJ, Broer J, Coenen AJ; PILOT CT Study Group. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: Results from the first national population based study in the Netherlands. Sex Transm Infect 2005;81:17-23.
  7. Wilson JS, Honey E, Templeton A, Paavonen J, Mårdh PA, Stray-Pedersen B; EU Biomed Concerted Action Group. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update 2002;8:385-94.
  8. Witkin SS. Immunity to heat shock proteins and pregnancy outcome. Infect Dis Obstet Gynecol 1999;7:35-8.
  9. Witkin SS, Sultan KM, Neal GS, Jeremias J, Grifo JA, Rosenwaks Z. Unsuspected Chlamydia trachomatis infection and in vitro fertilization outcome. Am J Obstet Gynecol 1994;171:1208-14.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.